01 Integration of Functional MRI with Advanced Brain Mapping Techniques The brain imaging and neuroimaging market analysis shows increasing integration of functional magnetic resonance imaging (fMRI) with advanced brain mapping techniques to identify brain regions involved in movement, language, memory, and other cognitive functions. Combining functional data with structural MRI helps clinicians and researchers examine brain activity and anatomical relationships more precisely.
02 Preference for Portable and Point-of-Care Neuroimaging Devices Interest in portable and point-of-care devices enables brain imaging in settings beyond conventional radiology departments. Compact imaging technologies, including portable low-field MRI systems, can support bedside assessment of selected neurological conditions and reduce the need to transport critically ill patients to centralized imaging facilities.
01 Supply chain disruptions are expected to have a high impact on the brain imaging and neuroimaging market share due to dependence on semiconductor chips, imaging detectors, and MRI components. The market is expected to follow a U-shaped recovery, as shortages of electronic components, manufacturing delays, and transportation constraints can postpone equipment production. The market is expected to grow at a CAGR of 8.27%, but supply chain constraints could lower this by 1.0 percentage point, resulting in a growth of around 7.27%. As supply conditions normalize, the brain imaging and neuroimaging market growth is expected to gradually return to 8.27%.
01 The brain imaging and neuroimaging market forecasts strategic investment activity driven by advances in high-resolution MRI and PET technologies.
02 Key Investment and Funding Activities in Brain Imaging and Neuroimaging Market, 2026 Company Value (USD) Details Luxembourg Institute of Health Approximately USD 432,000 In October 2026, the Luxembourg Institute of Health secured approximately USD 432,000 through the Luxembourg National Research Fund's TREK program to advance BrainEXP-AD, an AI-powered platform that derives Alzheimer's disease biomarker information from routine MRI scans. Wayne State University USD 2.54 million In August 2026, Wayne State University researchers received a five-year grant from the U.S. National Cancer Institute to advance PET imaging using a fluorine-18 tracer for detecting glioma infiltration and distinguishing tumor progression from radiation-related brain injury.
01 Demand for Early and Accurate Brain Disease Diagnosis and Neuroimaging in Traumatic Brain Injury Assessment Drives Market Demand for early and accurate diagnosis of brain diseases is increasing the use of neuroimaging systems to identify conditions such as brain tumors, dementia, and epilepsy. MRI and CT scans help clinicians detect structural abnormalities, assess disease progression, and guide treatment decisions. The need for timely diagnosis and appropriate clinical management is supporting demand for brain imaging and neuroimaging systems.Road accidents, falls, and sports-related injuries create demand for rapid brain imaging to detect bleeding, swelling, and other intracranial damage. CT scans are commonly used for the initial assessment of acute traumatic brain injuries, while MRI provides detailed evaluation when further examination is needed. The demand for timely injury detection and accurate assessment is contributing to the adoption of brain imaging and neuroimaging systems in emergency and trauma care.
01 Risk of Radiation Exposure and Limited Availability of Skilled Radiologists and Neuroimaging Specialists Restrain Market Expansion Certain brain imaging techniques, particularly computed tomography (CT) and positron emission tomography (PET), involve ionizing radiation that may pose health risks with repeated exposure. The need for radiation protection measures and careful patient selection can complicate imaging workflows and limit the use of certain neuroimaging procedures.Brain imaging and neuroimaging procedures require trained radiologists and specialists who can operate advanced imaging systems and interpret complex neurological findings accurately. Training requirements and the high cost of specialist recruitment can further increase operational expenses, restricting the expansion of neuroimaging services.
01 Expansion of AI-Based Image Analysis Tools and Imaging Solutions for Neurological Research Offers Growth Opportunities Medical imaging software developers can target hospitals, diagnostic imaging centers, and neurology practices seeking more efficient interpretation of brain scans. AI tools can help analyze MRI and CT images, identify suspicious abnormalities, and support the assessment of neurological conditions. Revenue opportunities include software licensing, subscription-based neuroimaging analysis platforms, and integration services for existing imaging systems, contributing to brain imaging and neuroimaging market growth.Imaging equipment manufacturers can target academic institutions, neuroscience research laboratories, and pharmaceutical companies studying brain function and neurological disorders. Advanced techniques, including functional MRI and diffusion tensor imaging, can support research into brain connectivity, neural activity, and disease-related structural changes.
September 2026 Telix Pharmaceuticals received U.S. FDA approval for Pixclara (floretyrosine F 18), a PET imaging agent for glioma in adults and children aged one month and older.
September 2026 Microstructure Imaging (MICSI) received U.S. FDA clearance for MICSI-PET, an MRI-guided PET imaging software platform designed for neurological applications.